| Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587) |
|---|
| 08/17/2005 | EP1562934A1 Amino-heterocycles as vr-1 antagonists for treating pain |
| 08/17/2005 | EP1562931A2 Anti-infective biaryl compounds |
| 08/17/2005 | EP1562925A1 Phenylalanine derivatives as dipeptidyl peptidase inhibitors for the treatment or prevention of diabetes |
| 08/17/2005 | EP1562898A1 Indole derivatives as somatostatin agonists or antagonists |
| 08/17/2005 | EP1562589A2 Diaminotriazoles useful as inhibitors of protein kinases |
| 08/17/2005 | EP1282418B1 Use of pyrazole derivatives for treating infertility |
| 08/17/2005 | EP0991638B1 NOVEL GUANIDINE MIMICS AS FACTOR Xa INHIBITORS |
| 08/17/2005 | EP0989982B1 Barbituric acid derivatives with antimetastatic and antitumor activity |
| 08/17/2005 | EP0894085B1 Benzyl(idene)-lactam derivatives, their preparation and their use as selective (ant)agonists of 5-ht1a- and/or 5-ht1d receptors |
| 08/17/2005 | CN1656109A Non nucleoside reverse transcriptase inhibitors |
| 08/17/2005 | CN1656090A Heterocyclic compounds which inhibit leukocyte adhesion mediated by alpha4 integrins |
| 08/17/2005 | CN1656082A Protein kinase inhibitors |
| 08/17/2005 | CN1656081A 4-anilino quinazoline derivatives as antiproliferative agents |
| 08/17/2005 | CN1656079A Pyrazole compounds and pharmaceutical compositions comprising the compound |
| 08/17/2005 | CN1656073A Diaryl urea derivatives useful for the treatment of protein kinase dependent diseases |
| 08/17/2005 | CN1656069A 1-(aminoalkyl)-3-sulfonylindole and-indazole derivatives as 5-hydroxytryptamine-6 ligands |
| 08/17/2005 | CN1656066A Pharmaceutical combination |
| 08/17/2005 | CN1656046A Process for producing cyclic compound |
| 08/17/2005 | CN1215067C 哒嗪酮醛糖还原酶抑制剂 Pyridazinone aldose reductase inhibitors |
| 08/17/2005 | CN1215061C Process for preparing anticancer compound, and intermediate |
| 08/16/2005 | US6930136 For use on metal substrates or in adhesive, sealant or coating compositions for use in proximity to metal substrates |
| 08/16/2005 | US6930124 Drug for detaching tumor |
| 08/16/2005 | US6930116 Such as 4-chloro-5-(2-phenyl-thiazol-5-yl)-2H-pyrazole-3-carboxylic acid ethyl amide; for inhibiting topoisomerases; treating bacterial infections in mammals |
| 08/16/2005 | US6930113 For therapy and prophylaxis of sexual dysfunctios; hypertension, pulmonary hypertension, congestive heart failure, renal failure, myocardial infraction, stable, unstable and variant (Prinzmetal) angina, atherosclerosis |
| 08/16/2005 | US6930110 Nitrogen compounds such as 5-chloro-4-{4-[4-(2,3-dihydrobenzo[1,4]dioxine-5-yl)-piperazine-1-yl]-butylamino}-2H-piridazin-3-one, used as anxiolytic and hypotensive agents; side effect reduction |
| 08/16/2005 | US6930107 treating obesity, overweight condition, hyperlipidemia, thyroid disease, hypothyroidism, thyroid cancer and related disorders |
| 08/16/2005 | CA2342974C Methods and compositions for inhibition of angiogenesis |
| 08/16/2005 | CA2323703C New cyano-indole serotonin reuptake inhibitors, the procedure for preparing them and the pharmaceutical formulations that contain them |
| 08/16/2005 | CA2106642C Carbazolone derivatives and process for preparing the same |
| 08/11/2005 | WO2005073221A1 HETEROCYCLIC MODULATORS OF THE GLUCOCORTICOID RECEPTOR, AP-1, AND/OR NF-κB ACTIVITY AND USE THEREOF |
| 08/11/2005 | WO2005073220A1 Remedy for irritable bowel syndrome with diarrhea |
| 08/11/2005 | WO2005073219A1 Fused heteroaryl derivatives for use as p38 kinase inhibitors in the treatment of i.a. rheumatoid arthritis |
| 08/11/2005 | WO2005073189A1 Fused heteroyral derivatives for use as p38 kinase inhibitors |
| 08/11/2005 | WO2005072733A1 Dyarylurea compounds as chk-1 inhibitors |
| 08/11/2005 | WO2005072730A1 Therapeutic agent for diarrhea-type irritable bowel syndrome |
| 08/11/2005 | WO2005051302A3 Bicyclic inhibitors of mek and methods of use thereof |
| 08/11/2005 | WO2005044807A3 Benzoimidazole compounds |
| 08/11/2005 | WO2005041858A3 Mucin production inhibitor |
| 08/11/2005 | US20050176966 Process for the preparation of pyrimidine derivative, intermediate therefor and process for the preparation thereof |
| 08/11/2005 | US20050176905 Monomer with anti-microbial character, polymer using the same, and manufacturing method thereof |
| 08/11/2005 | US20050176802 Pyrrole substituted 2-indolinone protein kinase inhibitors |
| 08/11/2005 | US20050176799 drugs such as 1-Benzyl-3-(2-furyl)-5-trifluoromethylpyrazole, capable of modulating biosynthesis of cyclic guanosine monophosphate, used for therapy and prophylaxis of cardiovascular disorders such as hypertension, angina pectoris, cardiac insufficiency, thrombosis or atherosclerosis |
| 08/11/2005 | US20050176796 Tricyclic pyrazole derivatives, process for their preparation and their use as antitumor agents |
| 08/11/2005 | US20050176794 reacting 2-butyl-1,3-diazaspiro[4.4]non-1-ene-4-one and 5-(4'-bromomethylbiphenyl-2-yl)-1-trityl-1H-tetrazole in the presence of a phase transfer catalyst and immiscible solvents, to form 2-butyl-3-[2'-(triphenylmethyltetrazol-5-yl)-biphenyl-4-yl methyl]-1,3-diazaspiro[4.4]non-1-ene-4-one |
| 08/11/2005 | US20050176793 formed by dissolving Irbesartan in a mixture of haloalkane and alcohol solvents, then distilling off the solvent from the solution and drying; non-peptide angiotensin antagonist, used for treatment of cardiovascular disorders such as hypertension and heart failure |
| 08/11/2005 | US20050176771 4-fluoro-1-({[1-(methanesulfonyl)piperidin-4-yl]amino}acetyl)pyrrolidine-2-carbonitrile; insulin-dependent diabetes (type 1 diabetes), non insulin-dependent diabetes (type 2 diabetes), insulin-resistant disorders, obesity; dipeptidyl peptidase IV-inhibiting activity |
| 08/11/2005 | US20050176770 Novel 1,3-dihydro-2H-indol-2-one derivatives, process for preparing them and pharmaceutical compositions containing them |
| 08/11/2005 | US20050176760 and tumors; imino-, thiocarbonyl- or hydroxyimino-substituted N-heterocyclic amide compounds such as 2-(3-aminomethylphenylamino)-N-[3-chloro-4-(2-hydroxyiminopyrrolidin-1-yl)phenyl]-2-phenylacetamide |
| 08/11/2005 | US20050176759 7-sulfonyl-3-benzazepine derivatives as modulators of the dopamine receptor and their use for the treatment cns disorders |
| 08/11/2005 | US20050176733 Chk-1 inhibitors |
| 08/11/2005 | US20050176727 Male erectile dysfunction; 1-(3-chlorophenyl)-3-(4-pyridin-2-yl-piperazin-1-yl)propan-1-one O-methyloxime |
| 08/11/2005 | US20050176726 Pyrimidine ether derivatives; antiinflammatory; analgesic; antiarthritis; antirheumatic;diseases involving sensory nerve function; 2-((6-(4-((1S)-1-(4-fluorophenyl)ethyl)-1-piperazinyl)-4-pyrimidinyl)oxy)quinoline |
| 08/11/2005 | US20050176721 2,5-Diarylpyrazines, 2,5-diarylpyridines and 2,5-diarylprimidines |
| 08/11/2005 | US20050176716 (2,3-5,6 aryl-heteroaryl)-bicyclo(2,2,2,)octane-amide derivatives; antiinflammatory, obesity, antidiabetic agent, autoimmune disease, asthma, arthritis; non-steroidal; side effect reduction; pharmacokinetics |
| 08/11/2005 | US20050176713 Amide derivatives as glycogen synthase kinase 3-beta inhibitors |
| 08/11/2005 | US20050176712 Integrin expression inhibitor |
| 08/11/2005 | US20050176709 Selective NPY (Y5) antagonists |
| 08/11/2005 | US20050176705 5-Chloro-1-(3,5-dichloro-2-methoxy benzenesulfonyl)-4-piperazin-1-yl-1H-indole trifluoroacetic acid salt; 5-hydroxytryptamine (serotonin) HT6 receptor antagonists; antidepressant, anxiolytic agent, cognition activator; ADHD, Alzheimer's and Parkinson's disease, drug and nicotine abuse |
| 08/11/2005 | US20050176699 Benzodiazepine derivatives, preparation thereof and use thereof |
| 08/11/2005 | US20050176647 Having an alkylation site via a vinyl linker at the end of a pyrrole-imidazole polyamide; inhibits the expression of a specific gene; high anti-cancer activity |
| 08/11/2005 | US20050175858 Blue light emitter with large triplet energy band gap; color purity, luminescence efficiency. reduced power consumption |
| 08/11/2005 | US20050175856 Electroluminescent device |
| 08/11/2005 | US20050172420 Based on diaminobenzanilides or, more specifically (aminobenzoylamino),(sulfo-),(methoxy)anilines; stable aqueous solutions;nonbleeding/colorfastness; excellent degrees of exhaustion with high colour strength; dyeing natural or synthetic materials, particularly, paper; neutral or greenish-yellow hues |
| 08/11/2005 | DE102004003811A1 Substituierte N-Cyclohexylimidazolinone, Verfahren ihrer Herstellung und ihre Verwendung als Arzneimittel Substituted N-Cyclohexylimidazolinone, processes for their preparation and their use as medicaments |
| 08/11/2005 | DE102004003493A1 5-Phenylpyrimidine 5-phenylpyrimidines |
| 08/11/2005 | CA2555273A1 Heterocycle grafted monomers and related polymers and hybrid inorganic-organic polymer membranes |
| 08/10/2005 | EP1560824A1 Compounds useful as inhibitors of jak and other protein kinases |
| 08/10/2005 | EP1560823A1 4-substituted 1-aminocyclohexane derivatives for utilization as orl1-receptor and mu-opiate receptor ligands |
| 08/10/2005 | EP1560822A1 4-imidazol-1-ylmethyl-pyrimidine derivatives as ligands for gabaa receptors |
| 08/10/2005 | EP1560817A1 Methods and compositions of novel triazine compounds |
| 08/10/2005 | EP1560816A1 Quinazoline derivatives |
| 08/10/2005 | EP1560815A1 Novel pyrimidine-4,6-dicarboxamides for the selective inhibition of collagenases |
| 08/10/2005 | EP1560811A2 Pharmaceutical compositions as inhibitors of dipeptidyl peptidase-iv (dpp-iv) |
| 08/10/2005 | EP1560584A2 Fab i inhibitors |
| 08/10/2005 | EP1507769A4 Copper-catalysed ligation of azides and acetylenes |
| 08/10/2005 | EP1368340B1 Piperazine derivatives as melanocortin receptor agonists |
| 08/10/2005 | CN1653073A Substituted phenylacetic acids |
| 08/10/2005 | CN1653062A (imidazol-1-yl-methyl)-pyridazine as NMDA receptor blocker |
| 08/10/2005 | CN1653025A NK1 antagonists |
| 08/10/2005 | CN1652792A N3 alkylated benzimidazole derivatives as MEK inhibitors |
| 08/10/2005 | CN1652776A N3 alkylated benzimidazole derivatives as MEK inhibitors |
| 08/10/2005 | CN1651392A 2-and 2, 5-substituted phenylketoenols |
| 08/10/2005 | CN1214026C Indol-3-yl derivatives |
| 08/10/2005 | CN1214018C Morpholinones as light stabilizers |
| 08/10/2005 | CN1214013C HIV replication inhibiting pyrimidines |
| 08/09/2005 | US6927296 Improved preparation of alpha -polymorphic eletriptan hydrobromide, by salt formation in a solution of 2-butanone and water, distillation, dehydration, desolventizing; purity, white color crystals |
| 08/09/2005 | US6927232 Phenylethynyl and styryl derivatives of imidazole and fused ring heterocycles |
| 08/09/2005 | US6927230 Triazole derivatives |
| 08/09/2005 | US6927227 Heterocyclic containing biphenyl aP2 inhibitors and method |
| 08/09/2005 | US6927222 Compounds |
| 08/09/2005 | US6927214 Non-peptide GLP-1 agonists |
| 08/09/2005 | US6927193 And aryl sulfide derivatives |
| 08/09/2005 | US6926885 In-vivo diagnostic method by means of near infrared radiation |
| 08/09/2005 | CA2303217C Use of an angiotensin ii receptor antagonist for the preparation of drugs to increase the survival rate of renal transplant patients |
| 08/04/2005 | WO2005070922A2 Bis-indole pyrroles useful as antimicrobials agents |
| 08/04/2005 | WO2005070902A1 Therapeutic agents ii |
| 08/04/2005 | WO2005070900A1 N-4-(6- (heteo) aryl-pyrimidin-4-ylaminophenyl) -bezenesulfonamides as kinase inhibitors |
| 08/04/2005 | WO2005070899A1 5-phenylpyrimidines and their use as microbicides |
| 08/04/2005 | WO2005070898A1 Substituted n-cyclohexyl imidazolinones having an mch-modulatory effect |
| 08/04/2005 | WO2005070891A2 Compounds and methods of use |